STATE STREET CORP - TSCAN THERAPEUTICS INC ownership

TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 30 filers reported holding TSCAN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of TSCAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$106,752
+10.9%
41,700
+8.3%
0.00%
Q2 2023$96,250
+91.0%
38,500
+60.4%
0.00%
Q1 2023$50,400
+15.4%
24,000
-10.4%
0.00%
Q4 2022$43,684
+6.5%
26,800
+100.0%
0.00%
Q3 2022$41,000
-2.4%
13,4000.0%0.00%
Q2 2022$42,000
+20.0%
13,400
+6.3%
0.00%
Q1 2022$35,000
-36.4%
12,600
+3.3%
0.00%
Q4 2021$55,000
-46.1%
12,2000.0%0.00%
Q3 2021$102,00012,2000.00%
Other shareholders
TSCAN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
DC Funds, LP 630,000$2,835,00016.79%
DC Investments Management, LLC 35,563$160,0000.23%
Deer Management Co. LLC 1,245,505$5,605,0000.14%
Alphabet Inc. 1,077,080$4,847,0000.12%
RA Capital Management 1,255,317$5,649,0000.10%
HHLR ADVISORS, LTD. 1,282,976$5,773,0000.09%
Nan Fung Group Holdings Ltd 48,600$219,0000.06%
Baker Brothers Advisors 1,425,000$6,413,0000.03%
Tekla Capital Management LLC 200,000$900,0000.03%
Marquette Asset Management, LLC 21,618$97,0000.02%
View complete list of TSCAN THERAPEUTICS INC shareholders